BIOLIFE SOLUTIONS INC BLFS
BIOLIFE SOLUTIONS INC statistics & valuation
Market cap$1.4B
P / S14.6×
P / B3.8×
P / FCF131.7×
Net margin-4.8%
Return on equity-1.2%
FCF margin11.1%
Net cash$28.0M
Enterprise value USD$1.4B
Earnings yield EBIT/EV-1.2%
Return on capital-4.3%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 64.6% | 67.1% | 60.7% | — | — | — | — | 68.5% | 61.2% | — |
| Operating margin | -17.3% | -6.0% | -25.3% | -7.8% | -29.5% | -13.0% | -0.8% | 18.5% | -9.6% | — |
| Net margin | -4.8% | -27.0% | -100.0% | -183.4% | -7.5% | 4.1% | -6.1% | -126.7% | -22.8% | — |
| FCF margin | 11.1% | 7.0% | -27.8% | -24.8% | -10.9% | 9.7% | 2.0% | 9.4% | 4.2% | — |
| Return on assets | -1.1% | -5.1% | -16.5% | -31.1% | -1.6% | 0.8% | -1.8% | -55.0% | -20.7% | -86.7% |
| Return on equity | -1.2% | -5.8% | -20.1% | -38.4% | -1.9% | 1.0% | -3.8% | -170.9% | -24.9% | -217.1% |
| Debt / equity | 0.01× | 0.05× | 0.07× | 0.07× | 0.02× | 0.01× | 0.00× | — | — | 1.34× |
| Current ratio | 5.94 | 4.54 | 2.86 | 3.11 | 2.95 | 7.37 | 3.14 | 19.37 | 6.56 | 4.08 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.